As a key element of the PI3K/AKT/mTOR signaling pathway, AKT is one of the most important pathways involved in BC survival, invasiveness, metastasis, and drug-resistance (Hinz and Jucker, 2019; Khan et al., 2019). This evidence concerns the gene AKT1 and breast cancer.